BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Affuso F, Mercurio V, Ruvolo A, Pirozzi C, Micillo F, Carlomagno G, Grieco F, Fazio S. A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome. World J Cardiol 2012; 4(3): 77-83 [PMID: 22451856 DOI: 10.4330/wjc.v4.i3.77]
URL: https://www.wjgnet.com/1949-8462/full/v4/i3/77.htm
Number Citing Articles
1
Rosa Solà, Rosa-M Valls, José Puzo, José-Ramón Calabuig, Angel Brea, Anna Pedret, David Moriña, José Villar, Jesús Millán, Anna Anguera, Alberico Catapano. Effects of Poly-Bioactive Compounds on Lipid Profile and Body Weight in a Moderately Hypercholesterolemic Population with Low Cardiovascular Disease Risk: A Multicenter Randomized TrialPLoS ONE 2014; 9(8): e101978 doi: 10.1371/journal.pone.0101978
2
Ying Zhang, Jin Sun, Yun-Jiao Zhang, Qian-Yun Chai, Kang Zhang, Hong-Li Ma, Xiao-Ke Wu, Jian-Ping Liu. The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trialTrials 2016; 17(1) doi: 10.1186/s13063-016-1633-5
3
Ying Zhao, Yuan-Yuan Yang, Bao-Lin Yang, Ya-Wei Du, Da-Wei Ren, Hong-Mei Zhou, Jing Wang, Hui-Min Yang, Yao-Xian Wang, Ying-Ying Zhang, Sheng-Xian Wu. Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trialTrials 2021; 22(1) doi: 10.1186/s13063-021-05028-8
4
Anna Och, Marek Och, Renata Nowak, Dominika Podgórska, Rafał Podgórski. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the DiseaseMolecules 2022; 27(4): 1351 doi: 10.3390/molecules27041351
5
Jacob A. Walker, Benjamin M. Dorsey, Marjorie A. Jones. Nutraceuticals and Natural Product Pharmaceuticals2019; : 167 doi: 10.1016/B978-0-12-816450-1.00006-4
6
Arrigo F. G. Cicero, Alessandra Reggi, Angelo Parini, Martino Morbini, Martina Rosticci, Elisa Grandi, Claudio Borghi. Berberine and Monacolin Effects on the Cardiovascular Risk Profile of Women with Oestroprogestin-Induced HypercholesterolemiaHigh Blood Pressure & Cardiovascular Prevention 2014; 21(3): 221 doi: 10.1007/s40292-014-0052-5
7
Dongdong Wang, Jiansheng Huang, Ting Gui, Yaxin Yang, Tingting Feng, Nikolay T. Tzvetkov, Tao Xu, Zhibo Gai, Ying Zhou, Jingjie Zhang, Atanas G. Atanasov. SR-BI as a target of natural products and its significance in cancerSeminars in Cancer Biology 2022; 80: 18 doi: 10.1016/j.semcancer.2019.12.025
8
Angela Pirillo, Alberico Luigi Catapano. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studiesAtherosclerosis 2015; 243(2): 449 doi: 10.1016/j.atherosclerosis.2015.09.032
9
S. Montserrat-de la Paz, M.D. García-Giménez, M. Ángel-Martín, M.C. Pérez-Camino, A. Fernández Arche. Long-chain fatty alcohols from evening primrose oil inhibit the inflammatory response in murine peritoneal macrophagesJournal of Ethnopharmacology 2014; 151(1): 131 doi: 10.1016/j.jep.2013.10.012
10
Andrew A. Bremer. Resveratrol Use in Metabolic SyndromeMetabolic Syndrome and Related Disorders 2014; 12(10): 493 doi: 10.1089/met.2014.1505
11
Giuseppe Derosa, Angela D'Angelo, Arianna Vanelli, Pamela Maffioli. <p>An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia</p>Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 653 doi: 10.2147/DMSO.S232791
12
Giuseppe Derosa, Pamela Maffioli. Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practiceExpert Review of Endocrinology & Metabolism 2015; 10(3): 297 doi: 10.1586/17446651.2015.995630
13
Giuseppe Derosa, Angela D'Angelo, Pamela Maffioli. The role of selected nutraceuticals in management of prediabetes and diabetes: An updated review of the literaturePhytotherapy Research 2022; 36(10): 3709 doi: 10.1002/ptr.7564
14
Seema Patel. Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and consWorld Journal of Microbiology and Biotechnology 2016; 32(5) doi: 10.1007/s11274-016-2035-2
15
Muhammad Taher, Mohamad Shahreen Amri, Deny Susanti, Muhammad Badri Abdul Kudos, Anis Natasha Shafawi, Soraya Nur Yazid. Natural Bio-active Compounds2019; : 107 doi: 10.1007/978-981-13-7205-6_5
16
O. Sh. Oinotkinova, E. L. Nikonov, E. V. Kryukov, A. P. Baranov, M. I. Voevoda. Evolution of dyslipidemia: from etiological mechanisms to new targets of personalized preventive nutraceutical therapy with red yeast riceCardiovascular Therapy and Prevention 2019; 18(6): 88 doi: 10.15829/1728-8800-2019-6-88-98
17
Adrian V. Hernandez, Jennifer Hwang, Iram Nasreen, Dakota Sicignano, Vinay Pasupuleti, Kimberly Snow-Caroti, C. Michael White. Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-AnalysisJournal of Dietary Supplements 2024; 21(2): 242 doi: 10.1080/19390211.2023.2212762
18
Federica Fogacci, Maciej Banach, Dimitri P. Mikhailidis, Eric Bruckert, Peter P. Toth, Gerald F. Watts, Željko Reiner, John Mancini, Manfredi Rizzo, Olena Mitchenko, Daniel Pella, Zlatko Fras, Amirhossein Sahebkar, Michal Vrablik, Arrigo F.G. Cicero. Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trialsPharmacological Research 2019; 143: 1 doi: 10.1016/j.phrs.2019.02.028
19
Vivencio Barrios, Carlos Escobar, Arrigo Francesco Giuseppe Cicero, David Burke, Peter Fasching, Maciej Banach, Eric Bruckert. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidenceAtherosclerosis Supplements 2017; 24: 1 doi: 10.1016/j.atherosclerosissup.2016.10.003
20
Jesus Millán, Arrigo F.G. Cicero, Francisco Torres, Anna Anguera. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trialsClínica e Investigación en Arteriosclerosis 2016; 28(4): 178 doi: 10.1016/j.arteri.2016.03.002
21
Mark Houston. Integrative Medicine2018; : 264 doi: 10.1016/B978-0-323-35868-2.00027-X
22
Paolo Bellavite, Serafino Fazio, Flora Affuso. A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular PreventionMolecules 2023; 28(11): 4491 doi: 10.3390/molecules28114491
23
Giuseppe Derosa, Angela D'Angelo, Aldo Bonaventura, Lucio Bianchi, Davide Romano, Pamela Maffioli. Effects of berberine on lipid profile in subjects with low cardiovascular riskExpert Opinion on Biological Therapy 2013; 13(4): 475 doi: 10.1517/14712598.2013.776037
24
Donporn Wongwaiwech, Monthana Weerawatanakorn, Panatpong Boonnoun. Subcritical dimethyl ether extraction as a simple method to extract nutraceuticals from byproducts from rice bran oil manufactureScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78011-z
25
Valentina Mercurio, Giacomo Pucci, Giorgio Bosso, Valeria Fazio, Francesca Battista, Angela Iannuzzi, Nadia Brambilla, Cristina Vitalini, Massimo D'Amato, Giampaolo Giacovelli, Gaetano Vaudo, Giuseppe Schillaci, Ferruccio Galletti, Domenico Bonaduce. A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome and left ventricular hypertrophy: A multicenter, randomized, double-blind, placebo-controlled trialClinical Nutrition 2020; 39(5): 1379 doi: 10.1016/j.clnu.2019.06.026
26
Mohammad Bagherniya, Hamed Khedmatgozar, Omid Fakheran, Suowen Xu, Thomas P. Johnston, Amirhossein Sahebkar. Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasomePhytotherapy Research 2021; 35(9): 4804 doi: 10.1002/ptr.7118
27
Giuseppe Derosa, Pamela Maffioli, Arrigo FG Cicero. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trialsExpert Opinion on Biological Therapy 2012; 12(8): 1113 doi: 10.1517/14712598.2012.704014
28
Luc E. Gosselin, Lauren Chrapowitzky, Todd C. Rideout. Metabolic effects of α-lipoic acid supplementation in pre-diabetics: a randomized, placebo-controlled pilot studyFood & Function 2019; 10(9): 5732 doi: 10.1039/C9FO00390H
29
Yanwen Wang, Jeffrey A. Zidichouski. Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and HomeostasisCholesterol 2018; 2018: 1 doi: 10.1155/2018/7173920
30
Serafino Fazio, Valentina Mercurio, Flora Affuso, Paolo Bellavite. The Negative Impact of Insulin Resistance/Hyperinsulinemia on Chronic Heart Failure and the Potential Benefits of Its Screening and TreatmentBiomedicines 2023; 11(11): 2928 doi: 10.3390/biomedicines11112928
31
Arrigo F. G. Cicero, Alessandro Colletti. Combination Therapy In Dyslipidemia2015; : 127 doi: 10.1007/978-3-319-20433-8_11
32
Alireza Fatahian, Saeed Mohammadian Haftcheshmeh, Sara Azhdari, Helaleh Kaboli Farshchi, Banafsheh Nikfar, Amir Abbas Momtazi-Borojeni. Reviews of Physiology, Biochemistry and PharmacologyReviews of Physiology, Biochemistry and Pharmacology 2020; 178: 83 doi: 10.1007/112_2020_42
33
Touqeer Ahmed, Anwar-ul-Hassan Gilani, Mohammad Abdollahi, Maria Daglia, Seyed Fazel Nabavi, Seyed Mohammad Nabavi. Berberine and neurodegeneration: A review of literaturePharmacological Reports 2015; 67(5): 970 doi: 10.1016/j.pharep.2015.03.002
34
Matteo Pirro, Massimo Raffaele Mannarino, Vanessa Bianconi, Luis E. Simental-Mendía, Francesco Bagaglia, Elmo Mannarino, Amirhossein Sahebkar. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta -analysis of randomized controlled trialsPharmacological Research 2016; 110: 76 doi: 10.1016/j.phrs.2016.04.021
35
Felix Zulhendri, Munir Ravalia, Krishna Kripal, Kavita Chandrasekaran, James Fearnley, Conrad O. Perera. Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative ReviewAntioxidants 2021; 10(3): 348 doi: 10.3390/antiox10030348
36
Gong Chen, Wanbo Chen, Jinhong Xu, Guodong Ma, Xinge Hu, Guoxun Chen. The current trend and challenges of developing red yeast rice-based food supplements for hypercholesterolemiaJournal of Future Foods 2023; 3(4): 312 doi: 10.1016/j.jfutfo.2023.03.003
37
Shu-Jun FENG, Zhi-Han TANG, Ying WANG, Xin-Ying TANG, Tao-Hua LI, Wei TANG, Ze-Min KUANG. Potential protective effects of red yeast rice in endothelial function against atherosclerotic cardiovascular diseaseChinese Journal of Natural Medicines 2019; 17(1): 50 doi: 10.1016/S1875-5364(19)30009-3
38
Junjun Shen, Feijun Luo, Qinlu Lin. Policosanol: Extraction and biological functionsJournal of Functional Foods 2019; 57: 351 doi: 10.1016/j.jff.2019.04.024
39
Pan Xiong, Li Niu, Sam Talaei, Hamed Kord-Varkaneh, Cain C.T. Clark, Mihnea-Alexandru Găman, Jamal Rahmani, Masoumeh Dorosti, Seyed Mohammad Mousavi, Meysam Zarezadeh, Hossein Taghizade-Bilondi, Jitao Zhang. The effect of berberine supplementation on obesity indices: A dose– response meta-analysis and systematic review of randomized controlled trialsComplementary Therapies in Clinical Practice 2020; 39: 101113 doi: 10.1016/j.ctcp.2020.101113
40
Brenda De la Cruz-Concepción, Yaccil Adilene Flores-Cortez, Martha Isela Barragán-Bonilla, Juan Miguel Mendoza-Bello, Monica Espinoza-Rojo. Insulin: A connection between pancreatic β cells and the hypothalamusWorld Journal of Diabetes 2023; 14(2): 76-91 doi: 10.4239/wjd.v14.i2.76
41
Giuseppe Marazzi, Francesco Pelliccia, Giuseppe Campolongo, Silvia Quattrino, Luca Cacciotti, Maurizio Volterrani, Carlo Gaudio, Giuseppe Rosano. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart DiseaseThe American Journal of Cardiology 2015; 116(12): 1798 doi: 10.1016/j.amjcard.2015.09.023
42
娣 杨. The Efficacy of Berberine in the Treatment of Obese People: A Meta-AnalysisAdvances in Clinical Medicine 2024; 14(08): 550 doi: 10.12677/acm.2024.1482250
43
Karina G. Pérez-Rubio, Manuel González-Ortiz, Esperanza Martínez-Abundis, José A. Robles-Cervantes, María C. Espinel-Bermúdez. Effect of Berberine Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin SecretionMetabolic Syndrome and Related Disorders 2013; 11(5): 366 doi: 10.1089/met.2012.0183
44
Isabel De Castro-Orós, Rosa Solà, Rosa María Valls, Angel Brea, Pilar Mozas, Jose Puzo, Miguel Pocoví, Maria Cristina Vinci. Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with BerberinePLOS ONE 2016; 11(3): e0150785 doi: 10.1371/journal.pone.0150785
45
Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani. Complementary and Alternative Medicine2019; : 125 doi: 10.4018/978-1-5225-7039-4.ch006
46
Mark Houston. The role of nutrition and nutritional supplements in the treatment of dyslipidemiaClinical Lipidology 2014; 9(3): 333 doi: 10.2217/clp.14.25
47
Kyung-Hyun Cho. High-Density Lipoproteins as Biomarkers and Therapeutic Tools2019; : 115 doi: 10.1007/978-981-13-7383-1_3
48
Arrigo F. G. Cicero, Cormac Kennedy, Tamara Knežević, Marilisa Bove, Coralie M. G. Georges, Agnė Šatrauskienė, Peter P. Toth, Federica Fogacci. Efficacy and Safety of Armolipid Plus®: An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical TrialsNutrients 2021; 13(2): 638 doi: 10.3390/nu13020638
49
Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani. Recent Advances in Drug Delivery TechnologyAdvances in Medical Technologies and Clinical Practice 2017; : 160 doi: 10.4018/978-1-5225-0754-3.ch006
50
Yaping Zhou, Fuliang Cao, Feijun Luo, Qinlu Lin. Octacosanol and health benefits: Biological functions and mechanisms of actionFood Bioscience 2022; 47: 101632 doi: 10.1016/j.fbio.2022.101632
51
Elias Sanidas, Charalampos Grassos. The role of nutraceuticals in the treatment of primary dyslipidemiaHellenic Journal of Cardiology 2020; 61(1): 60 doi: 10.1016/j.hjc.2018.07.009
52
Mohamed Siliman Misha, Sandrine Destrumelle, Dylan Le Jan, Nahla M. Mansour, Lionel Fizanne, Khadija Ouguerram, Jean-Claude Desfontis, Mohamed-Yassine Mallem, Joseph L Roberts. Preventive effects of a nutraceutical mixture of berberine, citrus and apple extracts on metabolic disturbances in Zucker fatty ratsPLOS ONE 2024; 19(7): e0306783 doi: 10.1371/journal.pone.0306783
53
Yan Li, Hongli Ma, Yuehui Zhang, Hongying Kuang, Ernest Hung Yu Ng, Lihui Hou, Xiaoke Wu. Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trialTrials 2013; 14(1) doi: 10.1186/1745-6215-14-226
54
Seema Patel, Nadeem Akhtar. Fungi and their Role in Sustainable Development: Current Perspectives2018; : 739 doi: 10.1007/978-981-13-0393-7_38
55
Xiao-Ke Wu, Ernest HY Ng. Infertility in Women with Polycystic Ovary Syndrome2018; : 181 doi: 10.1007/978-3-319-45534-1_14
56
Stefano Gonnelli, Carla Caffarelli, Kostantinos Stolakis, Claudia Cuda, Nicola Giordano, Ranuccio Nuti. Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled StudyCurrent Therapeutic Research 2015; 77: 1 doi: 10.1016/j.curtheres.2014.07.003
57
Vanessa Bianconi, Massimo Raffaele Mannarino, Amirhossein Sahebkar, Teresa Cosentino, Matteo Pirro. Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease RiskCurrent Cardiology Reports 2018; 20(7) doi: 10.1007/s11886-018-0994-7
58
Miriam Méndez-del Villar, Manuel González-Ortiz, Esperanza Martínez-Abundis, Karina G. Pérez-Rubio, Roberto Lizárraga-Valdez. Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin SecretionMetabolic Syndrome and Related Disorders 2014; 12(10): 497 doi: 10.1089/met.2014.0082
59
Arrigo Fg Cicero, Elisa Tartagni, Claudio Borghi. Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction?Clinical Lipidology 2012; 7(5): 549 doi: 10.2217/clp.12.55